Bishwajit Kundu

Prof. Bishwajit Kundu

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
ASAbhishek Sharma
Abhishek Sharma
SRSasireka Rajendran
Sasireka Rajendran
ASAnkit Srivastava
Ankit Srivastava
SSSatyawati Sharma
Satyawati Sharma
BKBishwajit Kundu
Bishwajit Kundu

1 May 2015 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
NBNidhi K. Bhatia
Nidhi K. Bhatia
ASAnkit Srivastava
Ankit Srivastava
NKNidhi Katyal
Nidhi Katyal
NJNidhi Jain
Nidhi Jain
MKM. Ashhar I. Khan
M. Ashhar I. Khan
SDShashank Deep
Shashank Deep

31 January 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
PPPrashant Pradhan
Prashant Pradhan
APAshutosh Kumar Pandey
Ashutosh Kumar Pandey
AMAkhilesh Mishra
Akhilesh Mishra
PGParul Gupta
Parul Gupta
PTPraveen Kumar Tripathi
Praveen Kumar Tripathi
BKBishwajit Kundu
Bishwajit Kundu
This paper has been withdrawn by its authors. They intend to revise it in response to comments received from the research community on their technical approach and their interpretation of the results. If you have any questions, please contact the corresponding author.

30 September 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BKBishwajit Kundu
Bishwajit Kundu
NMNilesh R. Maiti
Nilesh R. Maiti
EJEric M. Jones
Eric M. Jones
KSKrystyna A. Surewicz
Krystyna A. Surewicz
DVDavid L. Vanik
David L. Vanik
WSWitold K. Surewicz
Witold K. Surewicz
One of the most intriguing disease-related mutations in human prion protein (PrP) is the Tyr to Stop codon substitution at position 145. This mutation results in a Gerstmann–Straussler–Scheinker-like disease with extensive PrP amyloid deposits in the brain. Here, we provide evidence for a spontaneous conversion of the recombinant polypeptide corresponding to the Y145Stop variant (huPrP23–144) from a monomeric unordered state to a fibrillar form. This conversion is characterized by a protein concentration-dependent lag phase and has characteristics of a nucleation-dependent polymerization. Atomic force microscopy shows that huPrP23–144 fibrils are characterized by an apparent periodicity along the long axis, with an average period of 20 nm. Fourier-transform infrared spectra indicate that the conversion is associated with formation of β-sheet structure. However, the infrared bands for huPrP23–144 are quite different from those for a synthetic peptide PrP106–126, suggesting conformational non-equivalence of β-structures in the disease-associated Y145Stop variant and a frequently used short model peptide. To identify the region that is critical for the self-seeded assembly of huPrP23–144 amyloid, experiments were performed by using the recombinant polypeptides corresponding to prion protein fragments 23–114, 23–124, 23–134, 23–137, 23–139, and 23–141. Importantly, none of the fragments ending before residue 139 showed a propensity for conformational conversion to amyloid fibrils, indicating that residues within the 138–141 region are essential for this conversion.

13 December 2011 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
SBSaurabh Bansal
Saurabh Bansal
ASAnkit Srivastava
Ankit Srivastava
GMGoutam Mukherjee
Goutam Mukherjee
Ramendra Pati PandeyRamendra Pati Pandey
Ramendra Pati Pandey
AVAnita Kamra Verma
Anita Kamra Verma
BKBishwajit Kundu
Bishwajit Kundu
Thermophilic l ‐asparaginases display high stability and activity at elevated temperatures. However, they are of limited use in leukemia therapy because of their low substrate affinity and reduced activity under physiological conditions. In an attempt to combine stability with activity at physiological conditions, 3 active‐site mutants of Pyrococcus furiosus l ‐asparaginase (PfA) were developed. The mutants, specifically K274E, showed improved enzymatic properties at physiological conditions as compared to the wild type. All variants were thermodynamically stable and resistant to proteolytic digestion. None of the enzymes displayed glutaminase activity, a highly desirable therapeutic property. All variants showed higher and significant killing of human cell lines HL60, MCF7, and K562 as compared to the Escherichia coli l ‐asparaginase. Our study revealed that increased substrate accessibility through the active site loop plays a major role in determining activity. A new mechanistic insight has been proposed based on molecular dynamics simulated structures, where dynamic flipping of a critical Tyr residue is responsible for the activity of thermophilic l ‐asparaginases. Our study not only resulted in development of PfA mutants with combination of desirable properties but also gave a mechanistic insight about their activity.—Bansal, S., Srivastava, A., Mukherjee, G., Pandey, R., Verma, A. K., Mishra, P., Kundu, B. Hyperthermophilic asparaginase mutants with enhanced substrate affinity and antineoplastic activity: structural insights on their mechanism of action. FASEB J. 26, 1161‐1171 (2012). www.fasebj.org

1 May 2017 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
SGSaurabh Gautam
Saurabh Gautam
SKSandip Karmakar
Sandip Karmakar
RBRadhika Batra
Radhika Batra
PSPankaj Sharma
Pankaj Sharma
PPPrashant Pradhan
Prashant Pradhan
PCPramit K. Chowdhury
Pramit K. Chowdhury